Affordable Access

Access to the full text

Intermittent Theta-Burst Stimulation Transcranial Magnetic Stimulation Increases GABA in the Medial Prefrontal Cortex: A Preliminary Sham-Controlled Magnetic Resonance Spectroscopy Study in Acute Bipolar Depression

Authors
  • Diederichs, Chad1
  • DeMayo, Marilena M.1, 2, 3, 4, 5, 6
  • Cole, Jaeden1, 2, 3
  • Yatham, Lakshmi N.7
  • Harris, Ashley D.2, 4, 5, 6
  • McGirr, Alexander1, 2, 3
  • 1 Department of Psychiatry, University of Calgary, Calgary, AB , (Canada)
  • 2 Hotchkiss Brain Institute, University of Calgary, Calgary, AB , (Canada)
  • 3 Mathison Centre for Mental Health Research and Education, Calgary, AB , (Canada)
  • 4 Department of Radiology, University of Calgary, Calgary, AB , (Canada)
  • 5 Child and Adolescent Imaging Research Program, University of Calgary, Calgary, AB , (Canada)
  • 6 Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB , (Canada)
  • 7 Department of Psychiatry, University of British Columbia, Vancouver, BC , (Canada)
Type
Published Article
Journal
Frontiers in Psychiatry
Publisher
Frontiers Media SA
Publication Date
May 11, 2021
Volume
12
Identifiers
DOI: 10.3389/fpsyt.2021.665402
Source
Frontiers
Keywords
Disciplines
  • Psychiatry
  • Brief Research Report
License
Green

Abstract

Background: Magnetic resonance spectroscopy (MRS) has been used to identify gamma-aminobutyric acid (GABA) alterations in mood disorders, particularly in the medial prefrontal cortex (mPFC) where decreased concentrations have been associated with anhedonia. In major depressive disorder (MDD), prior work suggests that repetitive transcranial magnetic stimulation (rTMS) increases mPFC GABA concentrations proportional to antidepressant response. To our knowledge, this has not been examined in acute bipolar depression. Methods: As part of a multicentre 4-week randomized, double-blind, sham-controlled trial using intermittent theta-burst stimulation (iTBS) of the left dorsolateral prefrontal cortex (DLPFC) in individuals with acute bipolar depression, we quantified mPFC GABA and Glx (glutamate+glutamine) concentrations using a 3T MRS scan at baseline and after the intervention. Depressive symptoms were measured using the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Depression Rating Scale-17 (HRDS-17), and anhedonia was measured using the Snaith-Hamilton Pleasure Scale (SHAPS). Results: The trial was terminated for futility and magnetic resonance spectroscopy data was acquired for 18 participants. At baseline, there were no associations between GABA or Glx concentrations and anhedonia, however GABA was negative correlated with depressive symptom severity on the HRDS-17. Compared to the sham-iTBS group, participants receiving active-iTBS had a significant increase in mPFC GABA concentrations. This was unrelated to antidepressant outcomes or improvements in anhedonia. Conclusion: Our data suggests that iTBS targeting the DLPFC is associated with physiological changes in the mPFC. In acute bipolar depression, our preliminary data suggests that mPFC GABA is dissociated from antidepressant iTBS treatment outcomes and anhedonia.

Report this publication

Statistics

Seen <100 times